Dr Brian Underdown

Guest Contributor
March 2, 2011

Dr Brian Underdown has been appointed chair of the board of directors at the Ontario Genomics Institute, replacing Dr Mark Poznansky who was recently appointed OGI's president and CEO (R$, December 13/10). Underdown is currently managing director of Lumira Capital, a venture capital firm focused on health and life sciences which he joined in 1997. Prior to entering the investment industry, he was assistant VP research at Sanofi Pasteur with responsibility for its Canadian Universities Research program. Underdown has been an OGI board member since 2004….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.